RenovoRx, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by RenovoRx, Inc. (Nasdaq: RNXT) on September 19, 2022. The filing reports the appointment of a new Chief Operating Officer and the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and corporate governance.
Material Changes
The primary material change reported is the appointment of Ms. Angela Gill Nelms as Chief Operating Officer, effective September 19, 2022. Her compensation package includes:
- Base Salary: $400,000 annually.
- Discretionary Bonus: Targeted at 35% of the annual base salary.
- Equity Grant: Stock option to purchase 274,230 shares of common stock with an aggregate grant date fair value of $765,000.
- Moving Expenses: Reimbursement up to $20,000.
Outlook, Risks, and Contingencies
The filing details a Change in Control and Severance Agreement with the following contingencies:
- Termination Outside Change in Control Period: If terminated without Cause or for Good Reason, Ms. Nelms receives 50% of annual base compensation, a pro-rated target bonus, and up to 6 months of COBRA reimbursement.
- Termination During Change in Control Period: If terminated without Cause or for Good Reason within one year of a Change in Control, she receives 100% of base compensation, up to 12 months of COBRA reimbursement, and full vesting of outstanding equity awards (excluding performance-based awards).
- Excise Tax Provision: Payments are subject to a "full or reduced" provision to avoid Section 280G excise taxes, whichever results in a higher net amount to the executive. No tax gross-ups are provided.
Investor Verification Checklist
- Verify the vesting schedule and exercise terms of the 274,230 stock options granted to Ms. Nelms.
- Review the full text of the Offer Letter (Exhibit 10.1) and Severance Agreement (Exhibit 10.2) for specific definitions of "Cause" and "Good Reason."
- Confirm the impact of the new executive appointment on the company's cash burn rate and future operating expenses.
- Check for any subsequent filings regarding the performance milestones associated with the equity grant.